The first high-throughput method to prove that the inhibitory effect of maslinic acid on the growth of human glioma cells may be achieved by the activation of apoptosis induction through MAPK and caspase/Bcl2/Bax signaling pathways. The gene discussed is BCL2; the disease is glioma.